Please complete the fields below:
Brain tumours account for a quarter of childhood cancer diagnoses and more than a third of childhood cancer deaths. Childhood brain tumours are treated aggressively to give each child the very best chance of survival. But survival comes at a cost, and many young patients are left with devastating long-term and late effects that severely impact on their future health and wellbeing.
Despite the devastating effects of brain tumours, they have not attracted the same level of research investment as research into some other childhood cancers. To counter this, in 2014, we launched our three-year Brain Tumour Initiative, with a pledge to invest at least £3m in new brain tumour research over this period.
In March 2015, we awarded the first major project grants under this call, at a total cost of £1.81m. In December 2016 the second phase of funding was agreed and an additional four projects were awarded at a total cost of£1.24m. This has brought our total expenditure of the Brain Tumour Initiative to over £3m as planned in 2014.
Four new projects at a total cost of £1.24m. For this second round we invited research applications which sought to enhance the effectiveness of therapy through improved drug delivery systems or the use of novel technologies. The four projects agreed for funding use distinctly different approaches to deliver treatments of brain tumour patients.
Four new projects at a total cost of £1.81m. An important feature of the four funded projects is that they are highly collaborative, with researchers working together to share samples, data and expertise for maximum progress.
Know someone who might be interested in fundraising?
Press release: embargoed until 00.01 hrs Friday 7th February 2014
Children with Cancer UK notes the publication of ...
Fanconi anaemia (FA) is a rare, inherited blood disorder that leads to bone marrow failure. Children with FA ...
Earlier this year, the partnership’s original target of £500,000 was revised to £1,000,000 as a result of Coral’s ...